Jonathan Wolleben’s Positive Outlook on Structure Therapeutics, Inc. Driven by Unique ...
Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst ...
TMCnet12 天
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic ...
Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025.
TMCnet15 天
Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration
10, 2025 /PRNewswire/ -- Iktos, a leader in Artificial Intelligence (AI) and Robotics for drug design, and Cube Biotech, a pioneer in membrane protein production and purification technologies, today ...
Yahoo Finance15 天
Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration
Partnership will leverage Iktos's AI-enabled drug discovery platform and Cube Biotech's advanced protein technologies to develop novel agonists of the Amylin Receptor PARIS and MONHEIM, Germany, Jan.
Iktos and Cube Biotech Announce Launch of Small Molecule AI Drug Discovery Collaboration
Iktos, a leader in Artificial Intelligence (AI) and Robotics for drug design, and Cube Biotech, a pioneer in membrane protein production and purification technologies, today announced a strategic ...
Taiwan News15 天
Sciwind Biosciences Announces Global Licensing and Collaboration Agreement for Metabolic ...
About Amylin Receptor Agonists: Islet amyloid polypeptide (Amylin ... including the long-acting GLP-1 peptide analog Ecnoglutide injection (NDA stage), oral GLP-1 peptide Ecnoglutide tablet XW004 ...